proline and daunorubicin

proline has been researched along with daunorubicin in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (80.00)29.6817
2010's0 (0.00)24.3611
2020's1 (20.00)2.80

Authors

AuthorsStudies
Muszyńska, A; Pałka, J; Wolczyński, S1
Baptiste, N; Chen, X; Friedlander, P; Prives, C1
Chen, M; Feng, W; Huang, Z1
Lei, HY; Xiao, XB; Zhao, XL1
Aalikhani, M; Alikhani, M; Bazi, Z; Oladnabi, M; Shamsabadi, F1

Other Studies

5 other study(ies) available for proline and daunorubicin

ArticleYear
The mechanism for anthracycline-induced inhibition of collagen biosynthesis.
    European journal of pharmacology, 2001, Jan-05, Volume: 411, Issue:1-2

    Topics: Antibiotics, Antineoplastic; Blotting, Western; Cell Survival; Cells, Cultured; Child; Chlorides; Collagen; Daunorubicin; Dipeptidases; Dose-Response Relationship, Drug; Doxorubicin; Fibroblasts; Humans; Hydrogen-Ion Concentration; Male; Manganese Compounds; Proline; Skin; Thymidine

2001
The proline-rich domain of p53 is required for cooperation with anti-neoplastic agents to promote apoptosis of tumor cells.
    Oncogene, 2002, Jan-03, Volume: 21, Issue:1

    Topics: Antineoplastic Agents; Apoptosis; Camptothecin; Carcinoma, Non-Small-Cell Lung; Cell Cycle; Clone Cells; Colchicine; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; Daunorubicin; DNA Damage; DNA, Neoplasm; Etoposide; Fluorouracil; Gene Expression Regulation, Neoplastic; Genes, p53; Humans; Lung Neoplasms; Models, Biological; Proline; Promoter Regions, Genetic; Protein Structure, Tertiary; Recombinant Fusion Proteins; Structure-Activity Relationship; Tetracycline; Transcription, Genetic; Tumor Cells, Cultured; Tumor Suppressor Protein p53

2002
[In vitro study of the apoptosis effect of DNR on HL-60 cells and its relationship with ROS, CER and NF-kappaB].
    Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi, 2002, Volume: 23, Issue:9

    Topics: Apoptosis; Caspase 3; Caspases; Ceramides; Daunorubicin; Dose-Response Relationship, Drug; HL-60 Cells; Humans; Immunohistochemistry; NF-kappa B; Proline; Proto-Oncogene Proteins c-myc; Reactive Oxygen Species; Thiocarbamates

2002
[Inhibitory effect of daunorubicin enhanced by PDTC on drug-resistant leukemic cells in vitro].
    Zhongguo shi yan xue ye xue za zhi, 2005, Volume: 13, Issue:3

    Topics: Antineoplastic Agents; Bone Marrow Cells; Cell Proliferation; Daunorubicin; Dose-Response Relationship, Drug; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Drug Synergism; Humans; Leukemia; Leukocytes, Mononuclear; Proline; Thiocarbamates; Tumor Cells, Cultured

2005
In silico drug repurposing for the treatment of heart diseases using gene expression data and molecular docking techniques.
    Biochemical and biophysical research communications, 2021, 10-01, Volume: 572

    Topics: Aminoisobutyric Acids; Aminopterin; Bridged Bicyclo Compounds, Heterocyclic; Cyclopropanes; Daunorubicin; Digoxin; Drug Repositioning; Gene Expression; Heart Diseases; Humans; Lactams, Macrocyclic; Leucine; Ligands; Methylergonovine; Molecular Docking Simulation; Morpholines; Proline; Quinoxalines; Sulfonamides

2021